Isis Pharmaceuticals, Inc. (ISIS) Posts Mixed Q4 Results

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q4 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $32.4 million versus the consensus estimate of $30.3 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cerebras Systems Inc. (CBRS) Misses Q2 EPS by $2.80, Misses on Revenue; Offers FY26 Revenue Guidance
• Alpha & Omega Semiconductor (AOSL) Tops Q4 EPS by 11c
• Harmonic (HLIT) Tops Q2 EPS by 12c; raises outlook